- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02513966
Decreased Consumption of Blood Components During Cardiac Surgery Procedures: Causes and Effects.
June 26, 2024 updated by: Universitaire Ziekenhuizen KU Leuven
There is a decrease in the amount of blood components used during cardiac surgery in the last four years.
As the hemovigilance team of the investigators' Hospital the investigators want to find out the causes and effects of this decrease.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
7835
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All patients undergoing cardiac surgery from 2010 untill 2014 in the University Hospitals of Leuven.
Description
Inclusion Criteria:
- patient underwent cardiac surgery between 2010 and 2014 in UZ Leuven
Exclusion Criteria:
- patient without cardiac surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
amount of blood use during Cardiac surgery
Time Frame: 5years
|
5years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Timothy Devos, master, Universitaire Ziekenhuizen KU Leuven
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2015
Primary Completion (Actual)
May 17, 2022
Study Completion (Actual)
May 18, 2022
Study Registration Dates
First Submitted
July 13, 2015
First Submitted That Met QC Criteria
July 31, 2015
First Posted (Estimated)
August 3, 2015
Study Record Updates
Last Update Posted (Actual)
June 27, 2024
Last Update Submitted That Met QC Criteria
June 26, 2024
Last Verified
April 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- s58228
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Transfusion
-
Wellspect HealthCareCompletedArthroplasty, Replacement, Knee | Blood Transfusion | Blood Transfusion, AutologousPoland
-
Wellspect HealthCareCompletedBlood Transfusion | Arthroplasty, Replacement, Hip | Blood Transfusion, AutologousAustria, Netherlands, Norway, Spain
-
Mariah ArifCompletedMortality | Blood Transfusion | Transfusion | Trauma CoagulopathyUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBlood Transfusion | Orthopedic Surgery | Orthopedic Procedures | Cardiovascular Surgical Procedure | Blood Transfusion, Autologous
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); University of Pittsburgh; Strathmore... and other collaboratorsActive, not recruiting
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)Completed
-
Cardiochirurgia E.H.Completed
-
University of Colorado, DenverCompleted
-
Diskapi Teaching and Research HospitalCompleted
-
Clinic for Cardiovascular Diseases MagdalenaCompleted